16552-67-3 Usage
Uses
Used in Pharmaceutical Research and Development:
5-Bromo-3-methyl-2-azanaphthalene is utilized as a building block in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs and drug intermediates. Its unique structure allows for the creation of a variety of compounds with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 5-Bromo-3-methyl-2-azanaphthalene is employed as a key intermediate, facilitating the production of a range of chemical compounds that may have diverse applications across different industries.
Used in Antimicrobial and Antifungal Applications:
5-Bromo-3-methyl-2-azanaphthalene is used as an antimicrobial and antifungal agent due to its inherent properties that exhibit activity against various microorganisms. This makes it a promising candidate for research and development in the medical field, particularly for the creation of new treatments and preventive measures against microbial infections.
Used in Chemical Compound Development:
5-Bromo-3-methyl-2-azanaphthalene is used as a precursor in the development of new chemical compounds, leveraging its unique structural features to enhance the properties and functionalities of the resulting products in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 16552-67-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,5,5 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16552-67:
(7*1)+(6*6)+(5*5)+(4*5)+(3*2)+(2*6)+(1*7)=113
113 % 10 = 3
So 16552-67-3 is a valid CAS Registry Number.
16552-67-3Relevant articles and documents
SUBSTITUTED AROMATIC CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS
-
Page/Page column 139; 140, (2010/11/18)
The invention relates to substituted aromatic carboxamide and urea derivatives, to processes for the preparation thereof, to pharmaceutical compositions containing these compounds and also to the use of these compounds for preparing pharmaceutical compositions (formula (I)).
GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
-
Page/Page column 52-53, (2010/04/06)
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
